Cuban drug used for lung cancer therapy may be used in Serbian clinical study
Cuban drug used for lung cancer therapy may be used in Serbian clinical study
In Serbia, a memorandum on the procurement of 1,680 units of the CimaVax-EGF vaccine has been signed between the Cuban CIMAB and the Serbian Institute of Virology, Vaccines and Sera Torlak, Serbia’s Ministry of Health said on its official website.
The provided quantities of the drug are sufficient for a full medical treatment for 30 cancer patients that will be part of a clinical study, considering that the drug has not yet been registered in Serbia or in the EU reports
source: Balkans.com
Pingback: Cuban drug used for lung cancer therapy may be used in Serbian clinical study | Medicinno